Cardiac Dimensions, a Kirkland, WA-based firm which focuses on minimally invasive remedies for coronary heart failure and practical mitral regurgitation (FMR), raised $53M in Collection A funding.
The spherical was led by Ally Bridge Group, with participation from Claret Capital Companions, Cardiac Dimensions buyers Hostplus, M.H. Carnegie, Horizon 3 Healthcare, Lumira Ventures, and a confidential strategic investor.
The corporate intends to make use of the funds to fund for the completion of the EMPOWER Trial U.S. pivotal research and help the continued commercialization of the modern Carillon Mitral Contour System®.
Led by CEO and President Rick Wypych, Cardiac Dimensions develops minimally invasive therapy modalities to handle coronary heart failure and related cardiovascular situations. Its flagship expertise, the Carillon Mitral Contour System®, is designed to handle practical mitral regurgitation (FMR) utilizing a catheter-based method.
The corporate has operations in Kirkland, Washington, Sydney, Australia and Frankfurt, Germany.
FinSMEs
21/03/2025
